Embryonic stem cells: A great hope for a new era of medicine

Current Opinion in Drug Discovery and Development

Volumn 9, Issue 2, 2006, Pages 169-175

  Tutter, Antonin V ^a   Baltus, Gretchen A ^a   Kadam, Shilpa ^a  

^a NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

Cancer; Differentiation; Embryonic; Pluripotency; Stem cell

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ASCORBIC ACID; GROWTH FACTOR; HOMEODOMAIN PROTEIN; HOMEODOMAIN PROTEIN NANOG; MYOSIN; OCTAMER TRANSCRIPTION FACTOR 4; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PURMORPHAMINE; RETINOIC ACID; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG;

ASSAY; CANCER; CARDIOVASCULAR DISEASE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL FATE; CELL MIGRATION; DEGENERATIVE DISEASE; DIABETES MELLITUS; DRUG DESIGN; DRUG SCREENING; EMBRYO; EMBRYONIC STEM CELL; HUMAN; MEDICAL RESEARCH; MOUSE; MUSCULOSKELETAL DISEASE; NONHUMAN; PLURIPOTENT STEM CELL; REVIEW; SIGNAL TRANSDUCTION; STEM CELL TRANSPLANTATION; TOXICOLOGY;

ANIMALS; CELL DIFFERENTIATION; HUMANS; NEOPLASMS; SIGNAL TRANSDUCTION; STEM CELL TRANSPLANTATION; STEM CELLS; TOXICOLOGY;

EID: 33645063203     PISSN: 13676733     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (65)

1. Cookson C: Mother of all cells. Scientists hope for huge benefits from the surge of research on embryonic stem cells. Sci Am (2005) 293(1):A6-A11.
2. Ding S, Schultz PG: A role for chemistry in stem cell biology. Nat Biotechnol (2004) 22(7):833-840. Provides a review of the success and future potential of small molecules in mediating lineage-specific differentiation of stem cells.
3. Hochedlinger K, Yamada Y, Beard C, Jaenisch R: Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues. Cell (2005) 121(3):465-477. Describes the generation of a transgenic mouse in which the ES cell pluripotency regulator Oct4 is under the control of an inducible promoter, and demonstrates that forced expression of Oct4 in adult mice prevents the terminal differentiation of epithelial progenitor cells, which usually differentiate into gut epithelial cells throughout the life of the adult in a continual cycle of cell sloughing and regeneration. This block to differentiation causes intestinal hyperplasia, and provides a direct link between aberrant expression of an ES-specific gene and abnormal growth.
4. Zappone MV, Galli R, Catena R, Meani N, De Biasi S, Mattel E, Tiveron C, Vescovi AL, Lovell-Badge R, Ottolenghi S, Nicolis SK: Sox2 regulatory sequences direct expression of a β-geo transgene to telencephalic neural stem cells and precursors of the mouse embryo, revealing regionalization of gene expression in CNS stem cells. Development (2000) 127(11):2367-2382.
5. Munoz-Sanjuan I, Brivanlou AH: Neural Induction, the default model and embryonic stem cells. Nat Rev Neurosci (2002) 3(4):271-280.
6. Ying QL, Nichols J, Chambers I, Smith A: BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell (2003) 116(3):281-292.
7. Yokota Y, Mori S: Role of Id family proteins in growth control. J Cell Physiol(2002) 190(1):21-28.
8. Pera MF, Trounson AO: Human embryonic stem cells: Prospects for development Development (2004) 131 (22):5515-5525.
9. Ginis I, Luo Y, Miura T, Thies S, Brandenberger R, Gerecht-Nir S, Amit M, Hoke A, Carpenter MK, Itskovitz-Eldor J, Rao MS: Differences between human and mouse embryonic stem cells. Dev Biol (2004) 269(2):360-380.
10. Wang L, Li L, Menendez P, Cerdan C, Bhatia M: Human embryonic stem cells maintained in the absence of mouse embryonic fibroblasts or conditioned media are capable of hematopoietic development. Blood (2005) 105(12):4598-4603.
11. Xu RH, Peck RM, LJ DS, Feng X, Ludwig T, Thomson JA: Basic FGF and suppression of BMP signaling sustain undifferentiated proliferation of human ES cells. Nat Methods (2005) 2(3):185-190. Defines the culture conditions for long-term propagation of human ES cells in the absence of a feeder layer.
12. Heinrich PC, Behrmann I, Müller-Newen G, Schaper F, Graeve L: Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Biochem J (1998) 334(Pt 2):297-314.
13. Sato N, Meijer L, Skaltsounis L, Greengard P, Brivanlou AH: Maintenance of pluripotency In human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat Med (2004) 10(1):55-63.
14. Humphrey RK, Beattie GM, Lopez AD, Bucay N, King CC, Firpo MT, Rose-John S, Hayek A: Maintenance of pluripotency in human embryonic stem cells is STAT3 independent Stem Cells (2004) 22(4):522-530. Reveals a significant regulatory difference between hES and mES cells by demonstrating that genes responsive to the transcription factor STAT3, which is critical for maintaining mES cells in the pluripotent state, do not contribute to pluripotency maintenance in hES cells.
15. Avilion AA, Nicolis SK, Pevny LH, Perez L, Vivian N, Lovell-Badge R: Multipotent cell lineages In early mouse development depend on Sox2 function. Genes Dev (2003) 17(1):126-140.
16. Chambers I, Colby D, Robertson M, Nichols J, Lee S, Tweedie S, Smith A: Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell (2003) 113(5):643-655. Describes the cloning and characterization of a critical factor for mES cell maintenance and self-renewal.
17. Donovan PJ: High Oct-ane fuel powers the stem cell. Nat Genet (2001) 29(3):246-247.
18. Mitsui K, Tokuzawa Y, Itoh H, Segawa K, Murakami M, Takahashi K, Maruyama M, Maeda M, Yamanaka S: The homeoproteln Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell (2003) 113(5):631-642.
19. Pan GJ, Chang ZY, Schöler HR, Pei D: Stem cell pluripotency and transcription factor Oct4. Cell Res (2002) 12(5-6):321-329.
20. Wichterie H, Lieberam I, Porter JA, Jessell TM: Directed differentiation of embryonic stem cells Into motor neurons. Cell (2002) 110(3):385-397.
21. Dasen JS, Tice BC, Brenner-Morton S, Jessell TM: A Hox regulatory network establishes motor neuron pool identity and target-muscle connectivity. Cell (2005) 123(3):477-491. Provides the first demonstration of a Hox transcriptional network controlling the identity of motor neurons and their pattern of connectivity in muscle tissue.
22. Takahashi T, Lord B, Schulze PC, Fryer RM, Sarang SS, Gullans SR, Lee RT: Ascorbic acid enhances differentiation of embryonic stem cells into cardiac myocytes. Circulation (2003) 107(14):1912-1916.
23. Vlahos CJ, Matter WF, Hui KY, Brown RF: A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem (1994) 269(7):5241-5248.
24. Hori Y, Rulifson IC, Tsai BC, Heit JJ, Cahoy JD, Kim SK: Growth inhibitors promote differentiation of insulin-producing tissue from embryonic stem cells. Proc Natl Acad Sci USA (2002) 99(25):16105-16110.
25. Deltour L, Leduque P, Blume N, Madsen O, Dubois P, Jami J, Bucchini D: Differential expression of the two nonallelic proinsulin genes in the developing mouse embryo. Proc Natl Acad Sci USA (1993) 90(2):527-531.
26. Edlund H: Pancreatic organogenesis - developmental mechanisms and Implications for therapy. Nat Rev Genet (2002) 3(7):524-532.
27. Hori Y, Gu X, Xie X, Kim SK: Differentiation of insulin-producing cells from human neural progenitor cells. PLoS Med (2005) 2(4):e103.
28. Gao J, Dennis JE, Muzic RF, Lundberg M, Caplan AI: The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion. Cells Tissues Organs (2001) 169(1):12-20.
29. Wu X, Ding S, Ding Q, Gray NS, Schultz PG: A small molecule with osteogenesis-inducing activity in multipotent mesenchymal progenitor cells. J Am Chem Soc (2002) 124(49):14520-14521.
30. Wu X, Walker J, Zhang J, Ding S, Schultz PG: Purmorphamine induces osteogenesis by activation of the hedgehog signaling pathway. Chem Biol (2004) 11(9):1229-1238.
31. Zhao Q, Xu J: [Embryonic stem cell test In screening of medicine and other chemicals.] Sheng Wu Yi Xue Gong Cheng Xue Za Zhi (2005) 22(1):181-184.
32. Piersma AH: Validation of alternative methods for developmental toxicity testing. Toxicol Lett (2004) 149(1-3):147-153.
33. Kehat I, Kenyagin-Karsenti D, Snir M, Segev H, Amit M, Gepstein A, Uvne E, Binah O, Itskovitz-Eldor J, Gepstein L: Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest (2001) 108(3):407-414.
34. Kehat I, Gepstein A, Spira A, Itskovitz-Eldor J, Gepstein L: High-resolution electrophysiological assessment of human embryonic stem cell-derived cardiomyocytes: A novel in vitro model for the study of conduction. Circ Res (2002) 91(8):659-661.
35. Mummery C, Ward D, van den Brink CE, Bird SD, Doevendans PA, Opthof T, Brutel de la Riviere A, Tertoolen L, van der Heyden M, Pera M: Cardiomyocyte differentiation of mouse and human embryonic stem cells. J Anat (2002) 200(Pt 3):233-242.
36. Choi D, Oh HJ, Chang UJ, Koo SK, Jiang JX, Hwang SY, Lee JD, Yeoh GC, Shin HS, Lee JS, Oh B: In vivo differentiation of mouse embryonic stem cells Into hepatocytes. Cell Transplant (2002) 11(4):359-368.
37. Yamada T, Yoshikawa M, Kanda S, Kato Y, Nakajima Y, Ishizaka S, Tsunoda Y: In vitro differentiation of embryonic stem cells into hepatocyte-like cells identified by cellular uptake of indocyanine green. Stem Cells (2002) 20(2):146-154.
38. Tez M: Is cancer an adaptation of the adult stem cell? Med Hypotheses (2006) 66(2):448-449.
39. Almstrup K, Hoei-Hansen CE, Wirkner U, Blake J, Schwager C, Ansorge W, Nielsen JE, Skakkebaek NE, Rajpert-De Meyts E, Leffers H: Embryonic stem cell-like features of testicular carcinoma in situ revealed by genome-wide gene expression profiling. Cancer Res (2004) 64(14):4736-4743.
40. Calhoun JD, Rao RR, Warrenfeltz S, Rekaya R, Dalton S, McDonald J, Stice SL: Transcriptional profiling of initial differentiation events in human embryonic stem cells. Biochem Biophys Res Commun (2004) 323(2):453-464.
41. Li XL, Eishi Y, Bai YQ, Sakai H, Akiyama Y, Tani M, Takizawa T, Koike M, Yuasa Y: Expression of the SRY-related HMG box protein Sox2 In human gastric carcinoma. Int J Oncol (2004) 24(2):257-263.
42. Skotheim RI, Lind GE, Monni O, Nesland JM, Abeler VM, Fossa SD, Duale N, Brunborg G, Kallioniemi O, Andrews PW, Lothe RA: Differentiation of human embryonal carcinomas in vitro and in vivo reveals expression profiles relevant to normal development Cancer Res (2005) 65(13):5588-5598.
43. Tsukamoto T, Inada K, Tanaka H, Mizoshita T, Mihara M, Ushijima T, Yamamura Y, Nakamura S, Tatematsu M: Down-regulation of a gastric transcription factor, Sox2, and ectopic expression of intestinal homeobox genes, Cdx1 and Cdx2: Inverse correlation during progression from gastric/Intestinal-mixed to complete intestinal metaplasia. J Cancer Res Clin Oncol (2004) 130(3):135-145.
44. Vamum-Finney B, Xu L, Brashem-Stein C, Nourigat C, Flowers D, Bakkour S, Pear WS, Bernstein ID: Pluripotent, cytokine-dependent, hematopoietic stem cells are immortalized by constitutive Notch1 signaling. Nat Med (2000) 6(11):1278-1281.
45. Pardal R, Clarke MF, Morrison SJ: Applying the principles of stem-cell biology to cancer. Nat Rev Cancer (2003) 3(12):895-902. Explains the concept of the cancer stem-cell model.
46. Lee HY, Kleber M, Hari L, Brault V, Suter U, Taketo MM, Kemler R, Sommer L: Instructive role of Wnt/β-catenin in sensory fate specification in neural crest stem cells. Science (2004) 303(5660):1020-1023.
47. Bhardwaj G, Murdoch B, Wu D, Baker DP, Williams KP, Chadwick K, Ling LE, Karanu FN, Bhatia M: Sonic hedgehog induces the proliferation of primitive human hematopoietic cells via BMP regulation. Nat Immunol (2001) 2(2):172-180.
48. Mishra L, Shetty K, Tang Y, Stuart A, Byers SW: The role of TGF-β and Wnt signaling in gastrointestinal stem cells and cancer. Oncogene (2005) 24(37):5775-5789. Discusses the concert of various signaling pathways required for gastrointestinal development and how their misregulation leads to gastrointestinal cancers.
49. Pinto D, Clevers H: Wnt control of stem cells and differentiation in the intestinal epithelium. Exp Cell Res (2005) 306(2):357-363.
50. Merrill BJ, Gat U, DasGupta R, Fuchs E: Tcf3 and Lef1 regulate lineage differentiation of multipotent stem cells in skin. Genes Dev (2001) 15(13):1688-1705.
51. Huelsken J, Vogel R, Erdmann B, Cotsarelis G, Birchmeier W: β-Catenin controls hair follicle morphogenesis and stem cell differentiation In the skin. Cell (2001) 105(4):533-545.
52. Galderisi U, Jori FP, Giordano A: Cell cycle regulation and neural differentiation. Oncogene (2003) 22(33):5208-5219.
53. Marutani M, Tonoki H, Tada M, Takahashi M, Kashiwazaki H, Hida Y, Hamada J, Asaka M, Moriuchi T: Dominant-negative mutations of the tumor suppressor p63 relating to early onset of glioblastoma multiforme. Cancer Res (1999) 59(19):4765-4769.
54. Park MS, Rosai J, Nguyen HT, Capodieci P, Cordon-Cardo C, Koff A: p27 and Rb are on overlapping pathways suppressing tumorigenesis in mice. Proc Natl Acad Sci USA (1999) 96(11):6382-6387.
55. Lee EY, Chang CY, Hu N, Wang YC, Lai CC, Herrup K, Lee WH, Bradley A: Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature (1992) 359(6393):288-294.
56. LeCouter JE, Kablar B, Whyte PF, Ying C, Rudnicki MA: Strain-dependent embryonic lethality in mice lacking the retinoblastoma-related p130 gene. Development (1998) 125(23):4669-4679.
57. Ezeh UI, Turek PJ, Reijo RA, Clark AT: Human embryonic stem cell genes Oct4, Nanog, Stellar and Gdf3 are expressed in both seminoma and breast carcinoma. Cancer (2005) 104(10):2255-2265.
58. Monk M, Holding C: Human embryonic genes re-expressed in cancer cells. Oncogens (2001) 20(56):8085-8091.
59. Hart AH, Hartley L, Parker K, Ibrahim M, Looijenga LH, Pauchnik M, Chow CW, Robb L: The pluripotency homeobox gene Nanog is expressed in human germ cell tumors. Cancer (2005) 104(10):2092-2098.
60. Hoei-Hansen CE, Almstrup K, Nielsen JE, Brask Sonne S, Graem N, Skakkebaek NE, Leffers H, Rajpert-De Meyts E: Stem cell plurlpotency factor Nanog is expressed in human fetal gonocytes, testicular carcinoma in situ and germ cell tumours. Histopathology (2005) 47(1)148-56.
61. Jones TD, Ulbright TM, Eble JN, Baldridge LA, Cheng L: Oct4 staining in testicular tumors: A sensitive and specific marker for seminoma and embryonal carcinoma. Am J Surg Pathol (2004) 28:935-940.
62. Hart AH, Hartley L, Ibrahim M, Robb L: Identification, cloning and expression analysis of the pluripotency promoting Nanog genes in mouse and human. Dev Dyn (2004) 230(1):187-198.
63. Boyer LA, Lee TI, Cole MF, Johnstone SE, Levine SS, Zucker JP, Guenther MG, Kumar RM, Murray HL, Jenner RG, Gifford DK et al: Core transcriptional regulatory circuitry In human embryonic stem cells. Cell (2005) 122(6):947-956. Describes the chromatin immunoprecipitation-coupled microarray ('ChIP-chip') approach, used to identify a complex transcription regulatory network under the control of the ES cell pluripotency regulators Oct4, Nanog and Sox2.
64. Horak CE, Snyder M: ChIP-chIp: A genomic approach for Identifying transcription factor binding sites. Methods Enzymol (2002) 360:469-483.
65. Fishman MC, Porter JA: Pharmaceuticals: A new grammar for drug discovery. Nature (2005) 437(7058):491-493.